Results 191 to 200 of about 241,661 (217)

Mechanism-driven nano-therapeutic platform integrating plant-derived compounds and membrane-active peptides reprograms inflammatory, cell cycle arrest, cGAS-STING, and apoptotic gene expression to quench colorectal cancer. [PDF]

Front Pharmacol
Ibrahim D, Khater SI, Abdelfattah-Hassan A, Babteen NA, Alqahtani LS, Qahl SH, Mostafa M, El-Shaer NO, Abdel-Raheem SM, Alkhayyal N, Alghamdi R, Khan N.   +11 more
europepmc   +1 more source

Targeted Degradation of CDK2: A New Strategy for Overcoming Cyclin E‑Driven Cancers. [PDF]

ACS Med Chem Lett
Renner AC, Kargbo RB.
europepmc   +1 more source

Cyclin K condensates bridge CDK12 to phosphorylate and drive oncogenic YAP activation in hepatocellular carcinoma. [PDF]

Sci Adv
Sun Y, Zhang Y, Yan W, Duan J, Qiao K, Yan G, Xue J, Wang J, Zhan M, Li Q, Wang H, Zhang Y.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cyclin E in Normal Physiology and Disease States

Trends in Cell Biology, 2021
Chen Chu, Yu Zhou, Piotr Sicinski
exaly  

Cyclin E-Induced Replicative Stress Drives p53-Dependent Whole-Genome Duplication

Cell, 2023
John Diffley, Jingkun Zeng
exaly  

Cyclin-Dependent Kinases and Cell-Cycle Transitions: Does One Fit All?

Nature Reviews Molecular Cell Biology, 2008
Tim Hunt, Helfrid Hochegger, Shunichi Takeda   +2 more
exaly